The Middle East and North Africa (MENA) region accounts for relatively little of the global clinical trial market but is growing. To capitalise on this growth Dubai-based CRO (contract research organisation) Clinart MENA is repositioning its business.
“As the CRO market in the region is relatively young, we believe we are perfectly positioned to grow the industry, learning from other emerging markets that started before us”, Alaa Assem, the new CEO of Clinart MENA, said.
Partnerships in Clinical Trials plans to start a conference in the MENA region.